These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14552587)

  • 21. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
    Chen XX; Gao F; Wang Q; Huang X; Wang D
    Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
    Yang Y; Alcaraz AA; Snyder JP
    J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallographic structure of tubulin: implications for dynamics and drug binding.
    Downing KH; Nogales E
    Cell Struct Funct; 1999 Oct; 24(5):269-75. PubMed ID: 15216882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship of taxol inferring from docking taxol analogues to microtubule binding site.
    Xiang F; Yu J; Yin R; Ma Y; Yu L
    Z Naturforsch C J Biosci; 2009; 64(7-8):551-6. PubMed ID: 19791508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The paclitaxel site in tubulin probed by site-directed mutagenesis of Saccharomyces cerevisiae beta-tubulin.
    Entwistle RA; Winefield RD; Foland TB; Lushington GH; Himes RH
    FEBS Lett; 2008 Jul; 582(16):2467-70. PubMed ID: 18570892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.
    Freedman H; Huzil JT; Luchko T; Ludueña RF; Tuszynski JA
    J Chem Inf Model; 2009 Feb; 49(2):424-36. PubMed ID: 19434843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure Based Drug Design and Molecular Docking Studies of Anticancer Molecules Paclitaxel, Etoposide and Topotecan using Novel Ligands.
    Yadav M; Dhagat S; Eswari JS
    Curr Drug Discov Technol; 2020; 17(2):183-190. PubMed ID: 30848204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel macrocyclic paclitaxel analogues.
    Metaferia BB; Hoch J; Glass TE; Bane SL; Chatterjee SK; Snyder JP; Lakdawala A; Cornett B; Kingston DG
    Org Lett; 2001 Aug; 3(16):2461-4. PubMed ID: 11483035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
    Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible binding site for paclitaxel at microtubule pores.
    Magnani M; Maccari G; Andreu JM; Díaz JF; Botta M
    FEBS J; 2009 May; 276(10):2701-12. PubMed ID: 19459933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S; Srivastava G; Sharma A
    Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insight into the stabilization of microtubules by taxanes.
    Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
    Elife; 2023 Mar; 12():. PubMed ID: 36876916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential assembly kinetics of alpha-tubulin isoforms in the presence of paclitaxel.
    Banerjee A; Kasmala LT
    Biochem Biophys Res Commun; 1998 Apr; 245(2):349-51. PubMed ID: 9571153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of structural requirements of anticancer activity at the paclitaxel/tubulin binding site using CoMFA and CoMSIA.
    Islam MN; Song Y; Iskander MN
    J Mol Graph Model; 2003 Jan; 21(4):263-72. PubMed ID: 12479926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a paclitaxel isomer: C-2-acetoxy-C-4-benzoate paclitaxel.
    Chen SH; Farina V; Vyas DM; Doyle TW
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2227-30. PubMed ID: 9873518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
    Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
    Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominant labeling of beta- over alpha-tubulin from porcine brain by a photoactivatable taxoid derivative.
    Combeau C; Commerçon A; Mioskowski C; Rousseau B; Aubert F; Goeldner M
    Biochemistry; 1994 May; 33(21):6676-83. PubMed ID: 7911324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.
    Xu S; Chi S; Jin Y; Shi Q; Ge M; Wang S; Zhang X
    J Mol Model; 2012 Jan; 18(1):377-91. PubMed ID: 21537957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of Tau binding to microtubules and its role in microtubule dynamics in live cells.
    Breuzard G; Hubert P; Nouar R; De Bessa T; Devred F; Barbier P; Sturgis JN; Peyrot V
    J Cell Sci; 2013 Jul; 126(Pt 13):2810-9. PubMed ID: 23659998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.